Literature DB >> 22942569

Transient leukemia in down syndrome: report of two cases with review of literature.

Alka V Gosavi1, Prashant S Murarkar, Dhaneshwar N Lanjewar, Ravishankar V Ravikar.   

Abstract

Transient leukemia (TL) also referred to as transient abnormal myelopoiesis (TAM) or transient myeloproliferative disorder (TMD) is a unique syndrome that frequently occurs in newborns with Down syndrome (DS). It manifests in the first few days of life and shows leukocytosis with blast cells in the blood and bone marrow. This leukemia resolves spontaneously within first few months of life in the majority of cases. In this report we describe two newborns with a karyotype of 47,XY,+21, presented with marked leukocytosis and many blast cells in the peripheral blood. In both the cases, the blasts disappeared and the total leukocyte count reverted to normal without any specific treatment.

Entities:  

Keywords:  Down syndrome; Transient abnormal myelopoiesis; Transient leukemia; Transient myeloproliferative disorder

Year:  2011        PMID: 22942569      PMCID: PMC3155711          DOI: 10.1007/s12288-011-0079-x

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  12 in total

1.  Down's syndrome with transient abnormal myelofibrosis.

Authors:  N Jindal; N Ghoshal; S K Kabra
Journal:  Indian Pediatr       Date:  2000-07       Impact factor: 1.411

2.  Hematopoietic disorders in Down syndrome.

Authors:  John K Choi
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

3.  Down's syndrome with transient myeloproliferative disorder.

Authors:  S M Dhaded; R Das; P Kumar; A Narang
Journal:  Indian Pediatr       Date:  1996-11       Impact factor: 1.411

4.  Down syndrome with transient myeloid leukemia and urological abnormality.

Authors:  Amar A Shah; Ashish A Mehta; Mahendra Desai; Anirudh V Shah
Journal:  Indian Pediatr       Date:  2003-02       Impact factor: 1.411

5.  Hematological disorders in Down syndrome: ten-year experience at a Tertiary Care Centre in North India.

Authors:  Anshu Awasthi; Reena Das; Neelam Varma; Jasmina Ahluwalia; Anju Gupta; R K Marwaha; Gurjeewan Garewal
Journal:  Pediatr Hematol Oncol       Date:  2005-09       Impact factor: 1.969

Review 6.  Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.

Authors:  Preetha D Prabhu; Geethamani V; S R Niveditha; B R Gayathri; S R Keshavamurthy
Journal:  Indian J Pathol Microbiol       Date:  2004-01       Impact factor: 0.740

Review 7.  Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.

Authors:  Sébastien Malinge; Shai Izraeli; John D Crispino
Journal:  Blood       Date:  2009-01-12       Impact factor: 22.113

8.  Risk factors for early death in neonates with Down syndrome and transient leukaemia.

Authors:  Hideki Muramatsu; Koji Kato; Nobuhiro Watanabe; Kimikazu Matsumoto; Tomohiko Nakamura; Yasuo Horikoshi; Junichi Mimaya; Chizuko Suzuki; Masahiro Hayakawa; Seiji Kojima
Journal:  Br J Haematol       Date:  2008-05-28       Impact factor: 6.998

9.  Transient leukemia.

Authors:  Hema Anand; Sameer Bakhshi; Renu Saxena
Journal:  Indian J Pathol Microbiol       Date:  2009 Apr-Jun       Impact factor: 0.740

10.  Differentiation of blast cells from a Down's syndrome patient with transient myeloproliferative disorder.

Authors:  J Suda; M Eguchi; Y Akiyama; Y Iwama; T Furukawa; Y Sato; Y Miura; T Suda; M Saito
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

View more
  2 in total

1.  Down syndrome with transient myeloproliferative disorder and Beta-thalassemia major.

Authors:  Amit Garg; Ankur Singh; Mohanaraj Ramachandran; Seema Kapoor
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-22       Impact factor: 0.900

2.  Extreme hyperleucocytosis of the premature.

Authors:  Esther Jansen; Judith Emmen; Thilo Mohns; Albertine Donker
Journal:  BMJ Case Rep       Date:  2013-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.